BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 27193795)

  • 1. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.
    Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Fujita N; Kubo Y; Aishima S; Shirabe K; Yoshiura T; Honda H
    Diagn Interv Radiol; 2015; 21(2):96-104. PubMed ID: 25698097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(2):173-81. PubMed ID: 16628028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.
    Nishie A; Yoshimitsu K; Asayama Y; Irie H; Aibe H; Tajima T; Shinozaki K; Nakayama T; Kakihara D; Shimada M; Aishima S; Yoshida K; Honda H
    AJR Am J Roentgenol; 2005 Apr; 184(4):1157-62. PubMed ID: 15788587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
    Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
    Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.
    Sano S; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Aramaki T; Nakanuma Y; Uesaka K
    Anticancer Res; 2018 Sep; 38(9):5505-5512. PubMed ID: 30194209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
    Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
    PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma.
    Apisarnthanarak P; Pansri C; Maungsomboon K; Thamtorawat S
    J Med Assoc Thai; 2014 Apr; 97(4):415-22. PubMed ID: 24964684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic peripheral cholangiocarcinoma: CT evaluation.
    Valls C; Gumà A; Puig I; Sanchez A; Andía E; Serrano T; Figueras J
    Abdom Imaging; 2000; 25(5):490-6. PubMed ID: 10931983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
    Ni T; Shang XS; Wang WT; Hu XX; Zeng MS; Rao SX
    Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.